Dr. John Marshall on Differentiating Squamous and Adenocarcinoma in GI Cancers

John L. Marshall, MD
Published: Thursday, Jun 30, 2016


John L. Marshall, MD, chief, Division Of Hematology/Oncology, Georgetown University Hospital Associate Director, clinical research, Lombardi Comprehensive Cancer Center at Georgetown University Hospital, discusses the difference between squamous and adenocarcinoma in esophageal and gastric cancer.

Squamous cell carcinoma and adenocarcinoma have different causes and molecular makeup in esophageal and gastric cancers, yet they are still being treated as one in the same. Marshall emphasizes that once oncologist differentiate between the 2 types of cancer and treat them individually, there will be better results and improvements in survival.

<<< View more from the 2016 World Congress on GI Cancer


John L. Marshall, MD, chief, Division Of Hematology/Oncology, Georgetown University Hospital Associate Director, clinical research, Lombardi Comprehensive Cancer Center at Georgetown University Hospital, discusses the difference between squamous and adenocarcinoma in esophageal and gastric cancer.

Squamous cell carcinoma and adenocarcinoma have different causes and molecular makeup in esophageal and gastric cancers, yet they are still being treated as one in the same. Marshall emphasizes that once oncologist differentiate between the 2 types of cancer and treat them individually, there will be better results and improvements in survival.

<<< View more from the 2016 World Congress on GI Cancer


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x